Heart failure: when form fails to follow function
The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Cardiac performance is normally determined by architectural, cellular, and molecular structures that determine the heart's form, and by physiological and biochemical mechanisms that regulate the function of these structures. Impaired adaptation of form to function in failing hearts contributes to two syndromes initially called systolic heart failure (SHF) and diastolic heart failure (DHF). In SHF, characterized by high end-diastolic volume (EDV), the left ventricle (LV) cannot eject a normal stroke volume (SV); in DHF, with normal or low EDV, the LV cannot accept a normal venous return. These syndromes are now generally defined in terms of ejection fraction (EF): SHF became 'heart failure with reduced ejection fraction' (HFrEF) while DHF became 'heart failure with normal or preserved ejection fraction' (HFnEF or HFpEF). However, EF is a chimeric index because it is the ratio between SV--which measures function, and EDV--which measures form. In SHF the LV dilates when sarcomere addition in series increases cardiac myocyte length, whereas sarcomere addition in parallel can cause concentric hypertrophy in DHF by increasing myocyte thickness. Although dilatation in SHF allows the LV to accept a greater venous return, it increases the energy cost of ejection and initiates a vicious cycle that contributes to progressive dilatation. In contrast, concentric hypertrophy in DHF facilitates ejection but impairs filling and can cause heart muscle to deteriorate. Differences in the molecular signals that initiate dilatation and concentric hypertrophy can explain why many drugs that improve prognosis in SHF have little if any benefit in DHF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, pathological hypertrophy often decompensates, reducing cardiac function and resulting in end-stage heart failure (72).”
From The Hippo signal transduction network for exercise physiologists (2016) · cites this paper as [72]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191 · cited 1×
“For example, SHF occurs more often in younger men with coronary artery disease, whereas DHF is more common in older hypertensive women.(51,52) These differences are due in part to the ability of increased diastolic wall stress to stimulate LV dilatation in SHF; for example in the uninfarcted myocardium following a myo…”
BackgroundESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428 · cited 1×
“tually contributes to the development of fibrosis, arrhythmias, progressive myocardial deterioration, and end-stage heart failure.(54)”
BackgroundHein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E. P., Klövekorn, W.-P., & Schaper, J. (2003) · Circulation · doi:10.1161/01.cir.0000051865.66123.b7 · Cited by 1,102
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065 · cited 1×
“A large number of signalling pathways are now known to participate in the regulation of cardiac architecture and molecular composition.(39) – 41 These complex networks include several cytoskeletal and related proteins that, by recognizing cell deformation as a signal to modify cardiac myocyte growth, can play a key ro…”
BackgroundDilated cardiomyopathy: the complexity of a diverse genetic architecture
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.105 · Cited by 1,025 · cited 1×
“Failure of form to follow function can also occur in familial cardiomyopathies.(59) Abnormal proteins in the hearts of patients with”
BackgroundThe Edwin Smith Surgical Papyrus
Breasted, J. H. (1931) · September/Oktober 1931 · doi:10.1515/9783112615263-011 · Cited by 724
Lee, D. S., Gona, P., Vasan, R. S., Larson, M. G., Benjamin, E. J., Wang, T. J., Tu, J. V., & Levy, D. (2009) · Circulation · doi:10.1161/circulationaha.108.815944 · Cited by 672
Left Ventricular Volumes and Ejection Fraction by Echocardiography
POMBO, J. F., TROY, B. L., & RUSSELL, R. O. (1971) · Circulation · doi:10.1161/01.cir.43.4.480 · Cited by 647 · cited 1×
“However, it was developments in echocardiography that led to the widespread use of EF for the evaluation of heart disease because these measurements are safe, non-invasive, relatively inexpensive, reasonably accurate and do not require exposure to ionizing radiation.(17)”
BackgroundUsefulness and limitations of radiographic methods for determining left ventricular volume
Dodge, H. T., Sandler, H., Baxley, W. A., & Hawley, R. R. (1966) · The American Journal of Cardiology · doi:10.1016/0002-9149(66)90191-3 · Cited by 618 · cited 2×
“who found that EF was low in many patients with heart disease, suggested that EF is a valid index of myocardial contractility, and Dodge et al.(21) concluded that a low EF ‘is evidence of left ventricular disease’ because they observed that EF, although generally normal in patients with compensated valvular heart dise…”
Background
Cited by
Cao, Z., Jia, Y., & Zhu, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081820 · Cited by 398
“Cases of HF can currently be divided into HFrEF and “heart failure with normal or preserved ejection fraction” (HFnEF or HFpEF), depending on the ejection fraction (EF) [57,58].”
BackgroundThe continuous heart failure spectrum: moving beyond an ejection fraction classification
Triposkiadis, F., Butler, J., Abboud, F. M., Armstrong, P. W., Adamopoulos, S., Atherton, J. J., Backs, J., Bauersachs, J., Burkhoff, D., Bonow, R. O., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz158 · Cited by 265
“, that alter ventricular preload or afterload.(5,8) Furthermore, LVEF may be preserved or”
BackgroundCardiac aging and heart disease in humans
Steenman, M., & Lande, G. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0255-9 · Cited by 249
“As reviewed by Katz and Rolett (2016), concentric hypertrophy and a decreased LV cavity volume are hallmarks of HFpEF.”
BackgroundAutophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
Pisano, C., Balistreri, C. R., Ricasoli, A., & Ruvolo, G. (2017) · Mediators of Inflammation · doi:10.1155/2017/1274034 · Cited by 199
“Structural changes determine an increase in thickness of heart [12, 13] and vessel’s wall [14].”
Background
Metadata
- Authors
- Katz, A. M., & Rolett, E. L.
- Affiliations
- Dartmouth College (US)
- Corresponding author
- Rolett, Ellis L.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-24
- Volume
- 37
- Issue
- 5
- Pages
- 449-454
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2153868457
- Cited by
- 141
- References
- 58
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 31 · 2023: 13 · 2022: 15 · 2021: 11 · 2020: 11 · 2019: 14 · 2018: 7 · 2017: 9 · 2016: 15
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- heart failure, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, ejection fraction, left ventricular dilatation, concentric hypertrophy, end-diastolic volume, stroke volume, cardiac remodeling
- MeSH terms
- Cardiomyopathy, Dilated, Cytoskeletal Proteins, Heart Ventricles, Humans, Stress, Physiological, Stroke Volume, Signal Transduction, Ventricular Dysfunction, Heart Failure, Systolic, Heart Failure, Diastolic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heart failure: when form fails to follow function. https://app.cochat.ai/papers/10.1093/eurheartj/ehv548
- The paper
- Katz, A. M., & Rolett, E. L. (2016). Heart failure: when form fails to follow function. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv548
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.